LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.
News|Articles|May 13, 2026
BIOSECURE and Beyond: What it Really Means for Pharma Supply Chains
Author(s)Barbara Morgan
Barbara Morgan examines how the BIOSECURE act will affect supply chains.
Advertisement
Advertisement
The US pharmaceutical industry is entering a new phase of supply chain transformation.
Related to this article
Cardinal Health and McKesson moved to extend CVS Health distribution deals through June 2032, retaining their largest customer pending final contracts.
Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.
Mike Hennessy Jr. on the commercial assumptions being rewritten across pricing, patient engagement and supply chain in PC's October 2026 print issue.
In this Q&A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.
Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.
In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
GLP-1 demand is straining pharma cold chain capacity, from tighter temperature thresholds and rising load rejections to fuel costs and trailer backlogs.
Advertisement
Advertisement